updated 10/24/2005 9:02:32 AM ET 2005-10-24T13:02:32

Merck & Co. posted a 7 percent increase in third-quarter profit Monday as lower costs for materials and production offset a slight dip in revenues, mainly due to lost sales from Vioxx, the blockbuster pain pill the drugmaker withdrew a year ago over safety problems.

Merck, which also makes Zocor for high cholesterol and osteoporosis treatment Fosamax, reported net income of $1.42 billion, or 65 cents per share, the the July-September period. That beat by 3 cents a share the consensus forecast of analysts surveyed by Thomson Financial.

In the same period of 2004, Merck posted net income of $1.33 billion, or 60 cents per share.

Revenues totaled $5.42 billion, down 2 percent from $5.54 billion in 2004's third quarter.

For the first nine months of 2005, net income was $3.51 billion, or $1.59 per share. That was down 25 percent from $4.71 billion, or $2.11 per share, in the first three quarters of 2004. Nine-month revenue fell to $16.25 billion from $17.19 billion a year ago.

Copyright 2005 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 3.79%
$30K home equity loan FICO 4.99%
$75K home equity loan FICO 4.69%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.83%
Cash Back Cards 17.80%
Rewards Cards 17.18%
Source: Bankrate.com